Terms: = Lung cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315
96764 results:
1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
2. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
Lin M; Zhao A; Chen B
Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
[TBL] [Abstract] [Full Text] [Related]
3. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
[TBL] [Abstract] [Full Text] [Related]
4. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
Yin X; Liu X; Ren F; Meng X
Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
[TBL] [Abstract] [Full Text] [Related]
5. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
Sun Y; Ma Q; Chen Y; Liao D; Kong F
Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
[TBL] [Abstract] [Full Text] [Related]
6. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
7. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
Xing X; Li L; Sun M; Zhu X; Feng Y
Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic yield using electromagnetic navigation bronchoscopy for peripheral pulmonary nodules <2 cm.
Chen JY; Yang H; Lin XD; Yang H; Wen J; Liu QW; Zhang LJ; Lin P; Fu JH; Leng CS; Yi R; Luo KJ
Ther Adv Respir Dis; 2024; 18():17534666241249150. PubMed ID: 38757612
[TBL] [Abstract] [Full Text] [Related]
9. Long non‑coding RNA lung cancer‑associated transcript 1 regulates ferroptosis via microRNA‑34a‑5p‑mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
Tai F; Zhai R; Ding K; Zhang Y; Yang H; Li H; Wang Q; Cao Z; Ge C; Fu H; Xiao F; Zheng X
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757341
[TBL] [Abstract] [Full Text] [Related]
10. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract] [Full Text] [Related]
11. MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma.
Huang P; Zhao H; Sun R; Liu C; Wu L; Wang Y; Gan Z; Yang X; Du J
Sci Rep; 2024 May; 14(1):11211. PubMed ID: 38755247
[TBL] [Abstract] [Full Text] [Related]
12. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell lung cancer.
Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
[TBL] [Abstract] [Full Text] [Related]
13. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
14. Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.
Chang GC; Shih JY; Yu CJ; Chao HS; Yang CT; Lin CC; Hung JY; Hsiao SY; Wang CC; Chian CF; Hsia TC; Chen YM
PLoS One; 2024; 19(5):e0303046. PubMed ID: 38753697
[TBL] [Abstract] [Full Text] [Related]
15. Determinants and Factors of Physical Activity After Oncology Treatments (DEFACTO) in Metropolitan France: Protocol of a Mixed Methods Study and Intervention.
Aumaitre A; Gagnayre R; Foucaut AM
JMIR Res Protoc; 2024 May; 13():e52274. PubMed ID: 38753415
[TBL] [Abstract] [Full Text] [Related]
16. Leveraging Serial Low-Dose CT Scans in Radiomics-based Reinforcement Learning to Improve Early Diagnosis of lung cancer at Baseline Screening.
Wang Y; Zhou C; Ying L; Lee E; Chan HP; Chughtai A; Hadjiiski LM; Kazerooni EA
Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230196. PubMed ID: 38752718
[TBL] [Abstract] [Full Text] [Related]
17. Deep-Learning Model Prediction of Radiation Pneumonitis Using Pretreatment Chest Computed Tomography and Clinical Factors.
Lee JH; Kang MK; Park J; Lee SJ; Kim JC; Park SH
Technol Cancer Res Treat; 2024; 23():15330338241254060. PubMed ID: 38752262
[No Abstract] [Full Text] [Related]
18. Patterns of distant metastasis and survival outcomes in
Liu K; Huang AL; Chen XQ; Wu SG
Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
[TBL] [Abstract] [Full Text] [Related]
19. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
[TBL] [Abstract] [Full Text] [Related]
20. Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms.
Huang Z; Liang F; Wu J; Huang Z; Li Y; Huang X; Liu Z
BMC Pulm Med; 2024 May; 24(1):239. PubMed ID: 38750474
[TBL] [Abstract] [Full Text] [Related]
[Next]
